Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Endometriosis is very painful and can lead to infertility. It affects the outline tissue of the uterus and causes internal bleeding and inflammation. The global endometriosis market size is expected to expand by 2025. Symptoms of endometriosis are, for example, pain before and during the menstrual period, pain during ovulation and irregular or massive bleeding over some time, resulting in a significant reduction in the working female population. High prevalence, unknown etiology, and high productivity loss are the main factors that have led many research institutions and drug manufacturers to research the best diagnosis and treatment of the disease.
Gonadotropin-releasing hormone agonists, oral contraceptives, and progestin therapy are widely used for pain after diagnosis. The market share of non-steroidal anti-inflammatory drugs accounts for the major share of the global endometriosis market and is expected to maintain its dominant position. The supply of a large number of brands and generic products is expected to drive the growth of market segments soon.
In developed and developing countries, the increase in the female population aged 15-49 years is expected to drive the growth of the endometriosis drug market. It is expected that the high prevalence of endometriosis among women of childbearing age will drive the market demand for endometriosis treatment in the next few years. The growth of the female population during childbearing age, women's awareness of this disease continues to increase, and the development of new drugs for the treatment of endometriosis are some of the factors that have contributed to market growth. However, it takes more than seven years to diagnose the disease, and the lack of non-invasive diagnostic tests will increase patient suffering. Therefore, this factor may inhibit the growth of the endometriosis therapy market. Also, many important manufacturers are conducting extensive research in the development of advanced drugs and treatments for endometriosis, taking into account cost management, and such initiatives will drive market growth.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Endometriosis Therapies market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Endometriosis Therapies market. Detailed analysis of key players, along with key growth strategies adopted by Endometriosis Therapies industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
AstraZeneca
Bayer
Pfizer
Meditrina Pharmaceuticals
Eli Lilly
Takeda Pharmaceutical
Astellas Pharma
AbbVie
Neurocrine Biosciences
By Type:
Hormonal Contraceptives
Gonadotropin-releasing Hormone (Gn-RH) Agonists
Progestin Therapy
Aromatase Inhibitors
By End-User:
Hospital
Clinic
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Endometriosis Therapies Market
-
1.3 Market Segment by Type
-
1.3.1 USA Endometriosis Therapies Market Size and Growth Rate of Hormonal Contraceptives from 2016 to 2027
-
1.3.2 USA Endometriosis Therapies Market Size and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists from 2016 to 2027
-
1.3.3 USA Endometriosis Therapies Market Size and Growth Rate of Progestin Therapy from 2016 to 2027
-
1.3.4 USA Endometriosis Therapies Market Size and Growth Rate of Aromatase Inhibitors from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Endometriosis Therapies Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Endometriosis Therapies Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.3 USA Endometriosis Therapies Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Endometriosis Therapies Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Endometriosis Therapies by Major Types
-
3.4.1 Market Size and Growth Rate of Hormonal Contraceptives
-
3.4.2 Market Size and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists
-
3.4.3 Market Size and Growth Rate of Progestin Therapy
-
3.4.4 Market Size and Growth Rate of Aromatase Inhibitors
4 Segmentation of Endometriosis Therapies Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Endometriosis Therapies by Major End-Users
-
4.4.1 Market Size and Growth Rate of Endometriosis Therapies in Hospital
-
4.4.2 Market Size and Growth Rate of Endometriosis Therapies in Clinic
-
4.4.3 Market Size and Growth Rate of Endometriosis Therapies in Other
5 Market Analysis by Regions
-
5.1 USA Endometriosis Therapies Production Analysis by Regions
-
5.2 USA Endometriosis Therapies Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Endometriosis Therapies Landscape Analysis
-
6.1 West USA Endometriosis Therapies Landscape Analysis by Major Types
-
6.2 West USA Endometriosis Therapies Landscape Analysis by Major End-Users
7 South USA Endometriosis Therapies Landscape Analysis
-
7.1 South USA Endometriosis Therapies Landscape Analysis by Major Types
-
7.2 South USA Endometriosis Therapies Landscape Analysis by Major End-Users
8 Middle West USA Endometriosis Therapies Landscape Analysis
-
8.1 Middle West USA Endometriosis Therapies Landscape Analysis by Major Types
-
8.2 Middle West USA Endometriosis Therapies Landscape Analysis by Major End-Users
9 Northeast USA Endometriosis Therapies Landscape Analysis
-
9.1 Northeast USA Endometriosis Therapies Landscape Analysis by Major Types
-
9.2 Northeast USA Endometriosis Therapies Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 AstraZeneca
-
10.1.1 AstraZeneca Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Bayer
-
10.2.1 Bayer Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Pfizer
-
10.3.1 Pfizer Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Meditrina Pharmaceuticals
-
10.4.1 Meditrina Pharmaceuticals Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Eli Lilly
-
10.5.1 Eli Lilly Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Takeda Pharmaceutical
-
10.6.1 Takeda Pharmaceutical Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Astellas Pharma
-
10.7.1 Astellas Pharma Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 AbbVie
-
10.8.1 AbbVie Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Neurocrine Biosciences
-
10.9.1 Neurocrine Biosciences Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Endometriosis Therapies Market Size and Growth Rate of Hormonal Contraceptives from 2016 to 2027
-
Figure USA Endometriosis Therapies Market Size and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists from 2016 to 2027
-
Figure USA Endometriosis Therapies Market Size and Growth Rate of Progestin Therapy from 2016 to 2027
-
Figure USA Endometriosis Therapies Market Size and Growth Rate of Aromatase Inhibitors from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Endometriosis Therapies Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Endometriosis Therapies Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure USA Endometriosis Therapies Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Endometriosis Therapies Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Endometriosis Therapies
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Endometriosis Therapies by Different Types from 2016 to 2027
-
Table Consumption Share of Endometriosis Therapies by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Hormonal Contraceptives
-
Figure Market Size and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists
-
Figure Market Size and Growth Rate of Progestin Therapy
-
Figure Market Size and Growth Rate of Aromatase Inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Endometriosis Therapies by Different End-Users from 2016 to 2027
-
Table Consumption Share of Endometriosis Therapies by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Other
-
Table USA Endometriosis Therapies Production by Regions
-
Table USA Endometriosis Therapies Production Share by Regions
-
Figure USA Endometriosis Therapies Production Share by Regions in 2016
-
Figure USA Endometriosis Therapies Production Share by Regions in 2021
-
Figure USA Endometriosis Therapies Production Share by Regions in 2027
-
Table USA Endometriosis Therapies Consumption by Regions
-
Table USA Endometriosis Therapies Consumption Share by Regions
-
Figure USA Endometriosis Therapies Consumption Share by Regions in 2016
-
Figure USA Endometriosis Therapies Consumption Share by Regions in 2021
-
Figure USA Endometriosis Therapies Consumption Share by Regions in 2027
-
Table West USA Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table West USA Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure West USA Endometriosis Therapies Consumption Share by Types in 2016
-
Figure West USA Endometriosis Therapies Consumption Share by Types in 2021
-
Figure West USA Endometriosis Therapies Consumption Share by Types in 2027
-
Table West USA Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table West USA Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure West USA Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure West USA Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table South USA Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table South USA Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure South USA Endometriosis Therapies Consumption Share by Types in 2016
-
Figure South USA Endometriosis Therapies Consumption Share by Types in 2021
-
Figure South USA Endometriosis Therapies Consumption Share by Types in 2027
-
Table South USA Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table South USA Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure South USA Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure South USA Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table Middle West USA Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table Middle West USA Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Endometriosis Therapies Consumption Share by Types in 2016
-
Figure Middle West USA Endometriosis Therapies Consumption Share by Types in 2021
-
Figure Middle West USA Endometriosis Therapies Consumption Share by Types in 2027
-
Table Middle West USA Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure Middle West USA Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure Middle West USA Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table Northeast USA Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table Northeast USA Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Endometriosis Therapies Consumption Share by Types in 2016
-
Figure Northeast USA Endometriosis Therapies Consumption Share by Types in 2021
-
Figure Northeast USA Endometriosis Therapies Consumption Share by Types in 2027
-
Table Northeast USA Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure Northeast USA Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure Northeast USA Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Meditrina Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Meditrina Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Meditrina Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Meditrina Pharmaceuticals
-
Table Product and Service Introduction of Meditrina Pharmaceuticals
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Takeda Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical
-
Table Product and Service Introduction of Takeda Pharmaceutical
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Neurocrine Biosciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurocrine Biosciences
-
Figure Sales and Growth Rate Analysis of Neurocrine Biosciences
-
Figure Revenue and Market Share Analysis of Neurocrine Biosciences
-
Table Product and Service Introduction of Neurocrine Biosciences
-
